Formulation, Characterization, and Stability Assessment of a Novel Tobramycin-Loaded in Situ Gelling System for Enhanced Ocular Drug Retention
DOI:
https://doi.org/10.52783/jns.v14.3228Keywords:
In situ gelling system, Ocular drug delivery, Tobramycin ophthalmic formulation, Sustained drug release, Mucoadhesive polymersAbstract
This study aimed to develop and evaluate an in situ gelling ophthalmic formulation of Tobramycin for sustained drug release and enhanced ocular retention. The formulations were prepared using sodium alginate as a gelling agent and HPMC E50 LV or HPMC K4M as viscosity enhancers. The cold dispersion method was employed, and formulations were evaluated for clarity, pH, drug content, gelling capacity, viscosity, in vitro drug release, antimicrobial activity, ocular irritation, and stability. The formulations were clear and transparent, with a pH range of 6.48–6.52, ensuring ocular compatibility. Immediate gelation upon contact with simulated tear fluid led to controlled drug release over 10 hours, with IGF6 exhibiting the most sustained release. Rheological studies confirmed shear-thinning behaviour, allowing easy instillation and prolonged retention. Antimicrobial activity was comparable to the pure drug, ensuring effective bacterial inhibition. Ocular irritation studies in albino rabbits showed no signs of irritation or adverse effects, confirming safety for ophthalmic use. Accelerated stability studies demonstrated that IGF6 remained stable for one month with no significant changes in clarity, pH, viscosity, drug content, or release profile. The study concludes that Tobramycin-loaded in situ gelling formulations offer prolonged ocular retention, sustained drug release, and improved patient compliance. The optimized formulation (IGF6) showed superior stability and efficacy, making it a potential alternative to conventional eye drops for bacterial eye infections.
Downloads
Metrics
References
Agrawal, M., Pradhan, M., Singhvi, G., Patel, R., & Alexander, A. (2022). Thermoresponsive in situ gel of curcumin loaded solid lipid nanoparticle: design, optimization and in vitro characterization. Journal of Drug Delivery Science and Technology, 71, 103376.
Bonneau, N., Baudouin, C., Réaux‐le Goazigo, A., & Brignole‐Baudouin, F. (2022). An overview of current alternative models in the context of ocular surface toxicity. Journal of Applied Toxicology, 42(5), 718-737.
Cassano, R., Di Gioia, M. L., & Trombino, S. (2021). Gel-based materials for ophthalmic drug delivery. Gels, 7(3), 130.
Chavez-Esquivel, G., Cervantes-Cuevas, H., Ybieta-Olvera, L. F., Briones, M. T. C., Acosta, D., & Cabello, J. (2021). Antimicrobial activity of graphite oxide doped with silver against Bacillus subtilis, Candida albicans, Escherichia coli, and Staphylococcus aureus by agar well diffusion test: Synthesis and characterization. Materials Science and Engineering: C, 123, 111934.
Gambato, S., Bellotto, O., Mardirossian, M., Di Stasi, A., Gennaro, R., Pacor, S., Caporale, A., Berti, F., Scocchi, M., & Tossi, A. (2023). Designing new hybrid antibiotics: proline-rich antimicrobial peptides conjugated to the aminoglycoside tobramycin. Bioconjugate Chemistry, 34(7), 1212-1220.
Gaudana, R., Ananthula, H. K., Parenky, A., & Mitra, A. K. (2010). Ocular drug delivery. The AAPS journal, 12, 348-360.
González-González, O., Ramirez, I. O., Ramirez, B. I., O’Connell, P., Ballesteros, M. P., Torrado, J. J., & Serrano, D. R. (2022). Drug stability: ICH versus accelerated predictive stability studies. Pharmaceutics, 14(11), 2324.
Jodh, R., Tawar, M., Kachewar, A., Ingole, Y., Deshmukh, T., & Ijapure, V. (2022). Pharmacological Review on Tobramycin.
Kurniawansyah, I. S., Rusdiana, T., Sopyan, I., & Subarnas, A. (2021). A review on poloxamer and hydroxy propyl methyl cellulose combination as thermoresponsive polymers in novel ophthalmic in situ gel formulation and their characterization. Int. J. Appl. Pharm, 13(1), 27-31.
Nair, A. B., Shah, J., Jacob, S., Al-Dhubiab, B. E., Sreeharsha, N., Morsy, M. A., Gupta, S., Attimarad, M., Shinu, P., & Venugopala, K. N. (2021). Experimental design, formulation and in vivo evaluation of a novel topical in situ gel system to treat ocular infections. PloS one, 16(3), e0248857.
Neu, H. C. (1976). Tobramycin: an overview. The Journal of infectious diseases, S3-S19.
Nguyen, T. L. A., & Bhattacharya, D. (2022). Antimicrobial activity of quercetin: an approach to its mechanistic principle. Molecules, 27(8), 2494.
Osi, B., Khoder, M., Al-Kinani, A. A., & Alany, R. G. (2022). Pharmaceutical, biomedical and ophthalmic applications of biodegradable polymers (BDPs): literature and patent review. Pharmaceutical Development and Technology, 27(3), 341-356.
Patel, A., Cholkar, K., Agrahari, V., & Mitra, A. K. (2013). Ocular drug delivery systems: An overview. World journal of pharmacology, 2(2), 47.
Permana, A. D., Utomo, E., Pratama, M. R., Amir, M. N., Anjani, Q. K., Mardikasari, S. A., Sumarheni, S., Himawan, A., Arjuna, A., & Usmanengsi, U. (2021). Bioadhesive-thermosensitive in situ vaginal gel of the gel flake-solid dispersion of itraconazole for enhanced antifungal activity in the treatment of vaginal candidiasis. ACS Applied Materials & Interfaces, 13(15), 18128-18141.
Popa, L., Ghica, M. V., Popescu, R., Irimia, T., & Dinu-Pîrvu, C.-E. (2021). Development and optimization of chitosan-hydroxypropyl methylcellulose in situ gelling systems for ophthalmic delivery of bupivacaine hydrochloride. Processes, 9(10), 1694.
Sha, G., Liu, J., Jiang, Z., Zhu, M., Zhu, Y., Gu, C., Qian, Y., & Xi, J. (2023). In situ gels: The next new frontier in ophthalmic drug delivery system. Polymers for Advanced Technologies, 34(8), 2646-2662.
Tuwar, A., Mahajan, N., Gondkar, S., & Bachhav, R. (2023). An Overview of Ophthalmic In-Situ Gel. World Journal of Pharmaceutical Research, 12(12), 421-433.
Yoon, H.-J., Moon, J. Y., Kim, H. J., Park, S., Choi, J. S., Choi, H.-I., Kim, S., & Yoon, K. C. (2024). Evaluation of Ocular Irritation Sensitivity: Implications of Clinical Parameters, Pain Sensitivity, and Tear Neuromediator Profiles. Journal of Clinical Medicine, 14(1), 138.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
